BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT

MINNEAPOLIS, Jan. 5, 2024 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced Matthew F. McManus has been appointed President, Diagnostics and Genomics Segment, effective January 8, 2024. Dr. McManus succeeds Kim Kelderman, who will become Bio-Techne’s Chief Executive Officer effective February 1, 2024. Dr. McManus has over two decades of experience as a senior life sciences… Continue reading BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT

Nabla Raises $24M in Series B to Fuel Expansion of its Ambient AI Assistant to Transform Care Delivery

New financing, led by Cathay Innovation, will be used to expand capabilities and adoption of Nabla Copilot, the leading ambient AI assistant designed to alleviate the administrative burden placed on providers, and reduce clinician burnout. Launched in March 2023, Nabla Copilot has experienced rapid growth with +20,000 providers who have already adopted the solution for… Continue reading Nabla Raises $24M in Series B to Fuel Expansion of its Ambient AI Assistant to Transform Care Delivery

enCore Energy Provides Q4/23 ATM Quarterly Sales Update

NASDAQ:EUTSXV:EUencore uranium  DALLAS, Jan. 5, 2024 /PRNewswire/ – enCore Energy Corp. (“enCore” or the “Company”) (NASDAQ: EU) (TSXV: EU) announced today, as required by the TSXV, that the Company issued a total of 7,579,563  common shares, between the period October 1, 2023 and December 31, 2023, under the at-the-market (ATM) controlled equity offering program. The… Continue reading enCore Energy Provides Q4/23 ATM Quarterly Sales Update

MAXST Unveils Cutting-Edge XR Metaverse Platform at CES 2024

LAS VEGAS, Jan. 5, 2024 /PRNewswire/ — MAXST Co., Ltd. (KRX:377030), a leader in metaverse technology, will showcase its revolutionary metaverse development platform, MAXVERSE, at CES 2024 in Las Vegas from January 9 to 12 at Booth 15863. MAXST will highlight MAXVERSE, an all-in-one metaverse platform designed to seamlessly blend the real world into the metaverse and… Continue reading MAXST Unveils Cutting-Edge XR Metaverse Platform at CES 2024

Genprex Provides Business Update and Outlook for 2024

Acclaim-1 Phase 2a and Acclaim-3 Phase 1 clinical studies opening for enrollment in January 2024 Poised for FDA guidance regarding diabetes gene therapy program in 2024 AUSTIN, Texas, Jan. 5, 2024 /PRNewswire/ — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer… Continue reading Genprex Provides Business Update and Outlook for 2024

EndoQuest Robotics Partners with OMNIVISION to Equip Flexible Robotic System with Industry-leading Image Sensor

Novel flexible robotic system to offer best-in-class endoscopic visualization HOUSTON, Jan. 5, 2024 /PRNewswire/ — EndoQuest™ Robotics, Inc., a privately-held medical device company and pioneering leader in the development of innovative endoluminal robotic technologies, and OMNIVISION, a leading global developer of semiconductor solutions, including advanced digital imaging,  and touch display technology, announced today a partnership to… Continue reading EndoQuest Robotics Partners with OMNIVISION to Equip Flexible Robotic System with Industry-leading Image Sensor

DELFI Diagnostics Appoints Susan Tousi as New Chief Executive Officer

Tousi brings expansive commercial strategic vision to accelerate FirstLook Lung U.S. market introduction; succeeds DELFI founder Victor Velculescu, M.D., Ph.D., who remains a director on the company’s Board BALTIMORE and PALO ALTO, Calif., Jan. 5, 2024 /PRNewswire/ — DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer… Continue reading DELFI Diagnostics Appoints Susan Tousi as New Chief Executive Officer

Medtronic receives CE Mark for its next generation Micra leadless pacing systems

New pacemakers offer 40% more battery life,1 extend Medtronic legacy of pacing leadership DUBLIN, Jan. 5, 2024 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has received CE (Conformité Européenne) Mark for its Micra™ AV2 and Micra™ VR2, the next generation of its industry-leading miniature, leadless pacemakers. Micra… Continue reading Medtronic receives CE Mark for its next generation Micra leadless pacing systems

Polyvinyl Alcohol Films Market Analysis 2023-2033: Growing Environmental Awareness and Regulations Regarding Plastic Waste and Pollution Drives PVA Films Market

DUBLIN, Jan. 5, 2024 /PRNewswire/ — The “Polyvinyl Alcohol Films Market: A Global and Regional Analysis, 2023-2033” report has been added to ResearchAndMarkets.com’s offering. The global polyvinyl alcohol (PVA) films market is on a trajectory of robust growth, driven by a myriad of factors contributing to its widespread adoption across various industries. PVA films are highly… Continue reading Polyvinyl Alcohol Films Market Analysis 2023-2033: Growing Environmental Awareness and Regulations Regarding Plastic Waste and Pollution Drives PVA Films Market

Transforming the future of retail: Pricer showcases digital in-store automation solutions at NRF

STOCKHOLM, Jan. 5, 2024 /PRNewswire/ — Pricer, the global leader in retail in-store automation and communication, will exhibit at the National Retail Federation (NRF)’s Big Show, taking place in New York from January 14 to 16. Exhibiting at booth #6457, Pricer solutions, recognized the world over by Tier 1 retail, will showcase its latest in-store… Continue reading Transforming the future of retail: Pricer showcases digital in-store automation solutions at NRF